BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

South Korea

Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™

Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures opt...

September 30, 2022 | News

GC Labs obtain certification of CDC standardization programs (VDSCP & HoSt)

GC Labs, a leading South Korea clinical laboratory, today announced that it has recently obtained certification of standardization prog...

September 29, 2022 | News

Olympus Launches THUNDERBEAT Energy Device for Open Surgery

Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer, and more fulfilling, today announced the...

September 29, 2022 | News

'iSyncWave' EEG Scanner receives FDA 510k clearance

According to iMediSync, iSyncWave is a dry EEG scanner that does not require the use of electrode gel. It is not only easy to wear the device and meas...

September 26, 2022 | News

Lunit Showcases AI Solutions for Radiology at AOCR & KCR 2022

Lunit's demonstration focuses on how radiologists and AI solutions can create synergy through combined workflows Visitors invited to Lunit Demo Station ...

September 22, 2022 | News

Unstoppable Rise of Korean Medical Tourism

Korea Health Industry Development Institute (KHIDI) has revamped the official website of Medical Korea(www.medicalkorea.or.kr), featuring information relat...

September 20, 2022 | News

Qurient Announces Collaboration Agreement with MSD

Q901 is a novel highly selective CDK7 inhibitor Q901 is ready for dose escalation study in the U.S. for the treatment of selected advanced solid tumors ...

September 19, 2022 | News

Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East

Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...

September 02, 2022 | News

Merck to Acquire Chemical Business of Mecaro

Acquisition supports “Level Up” growth ambition of Merck’s Electronics business to further expand its regional capabilities and global ...

August 18, 2022 | News

Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study of BBT-877

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing novel drugs for cancer, fibrosis and inflammation, announ...

August 17, 2022 | News

ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis

ROKIT Healthcare, a company specializing in bio-healthcare, today announced it will provide a hyper-personalized medical platform that uses 3D bioprinting ...

August 15, 2022 | News

LG Chem Enters Final Stage of Clinical Development for New Gout Drug

In global Phase 3 clinical trial, Tigulixostat will be evaluated in 350 adult gout patients with hyperuricemia for safety and efficacy at Month 6 of treatm...

August 04, 2022 | News

GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities Technology transfer and scale-up from lab benc...

August 02, 2022 | News

GenKOre develops hypercompact adenine base editors (ABEs)

GenKOre (homepage: www.genkore.com) is a business spun off from the Korea Research Institute of Bioscience and Biotechnology (KRIBB), which is a gover...

August 02, 2022 | News

Stay Connected